Mainz Biomed (NASDAQ:MYNZ – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 77,800 shares, a decrease of 29.2% from the October 15th total of 109,900 shares. Currently, 0.7% of the shares of the stock are short sold. Based on […]
Mainz Biomed (NASDAQ:MYNZ – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 125,000 shares, a drop of 57.7% from the September 15th total of 295,700 shares. Based on an average daily volume of 119,600 shares, the […]
Cantor Fitzgerald reiterated their overweight rating on shares of Mainz Biomed (NASDAQ:MYNZ – Free Report) in a report issued on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $9.00 target price on the stock. Separately, HC Wainwright boosted their price target on shares of Mainz Biomed from $7.00 to $9.00 and gave the stock […]
Cantor Fitzgerald reissued their overweight rating on shares of Mainz Biomed (NASDAQ:MYNZ – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $9.00 price objective on the stock. Separately, HC Wainwright dropped their target price on shares of Mainz Biomed from $10.00 to $7.00 and set […]
Mainz Biomed (NASDAQ:MYNZ – Get Free Report) was the target of a large increase in short interest in August. As of August 15th, there was short interest totalling 22,800 shares, an increase of 168.2% from the July 31st total of 8,500 shares. Approximately 0.2% of the shares of the stock are short sold. Based on […]